Oxford Brain Diagnostics Appoints Jieun Choe as Chief Executive Officer
Position
Chief Executive Officer
Company
Oxford Brain Diagnostics
Description
Oxford Brain Diagnostics has appointed Jieun Choe as Chief Executive Officer as the company embarks on a pivotal growth stage. With her extensive experience, Choe aims to establish quantitative brain biology as a new standard for precision brain health.
Quick answer
Oxford Brain Diagnostics Appoints Jieun Choe as Chief Executive Officer (September 15, 2026). Oxford Brain Diagnostics is based in Oxford, England, United Kingdom.
- Who is the new Chief Executive Officer at Oxford Brain Diagnostics?
- Oxford Brain Diagnostics named Jieun Choe Chief Executive Officer, announced September 15, 2026.
- What did Oxford Brain Diagnostics announce on September 15, 2026?
- Oxford Brain Diagnostics has appointed Jieun Choe as Chief Executive Officer as the company embarks on a pivotal growth stage. With her extensive experience, Choe aims to establish quantitative brain biology as a new standard for precision brain health.
- What does Oxford Brain Diagnostics do?
- Oxford Brain Diagnostics (OBD) is a pioneer in quantitative brain biology, focused on advancing brain health through objective measurement.
- Where is Oxford Brain Diagnostics based?
- Oxford Brain Diagnostics is based in Oxford, England, United Kingdom.
- Which similar companies made leadership changes around the same time?
- AdvanCell (September 15, 2026), Serapha Bio (September 15, 2026), Vyome Holdings (September 14, 2026) and Q32 Bio (September 14, 2026) also announced leadership changes within 45 days of Oxford Brain Diagnostics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Health Diagnostics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AdvanCell Appoints Sean Cassidy as Chief Financial Officer (September 15, 2026)
- Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as Chief Financial Officer (September 15, 2026)
- Vyome Appoints Jerry Leonard as Chief Financial Officer (September 14, 2026)
- Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026)
- Paradigm Biopharmaceuticals Appoints Dr Daniel Furtner as Chief Medical Officer (September 17, 2026)
- Cyllene Therapeutics Appoints Marc Grasso as Chief Financial Officer (September 17, 2026)
Who to call at Oxford Brain Diagnostics, and when
A new leader at Oxford Brain Diagnostics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Oxford Brain Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oxford Brain Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oxford Brain Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oxford Brain Diagnostics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Oxford Brain Diagnostics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.